Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

290 Press Releases
DateTitleCompany
09 Nov 11 Teva to Present at the Credit Suisse 2011 Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Nov 11 Teva Announces Pricing of $5,000,000,000 of Senior Notes Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Nov 11 The Procter & Gamble Company and Teva Pharmaceutical Industries Announce Formation of New Consumer Health Care Partnership Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Nov 11 Teva Provides Updated 2011 Financial Outlook Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Nov 11 Teva Reports Third Quarter 2011 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Oct 11 Teva Presents New Data on QNASL™ at the 2011 American College of Allergy, Asthma and Immunology Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Oct 11 Teva and Dr. Reddy’s Announce Launch of Generic Zyprexa® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Oct 11 Treatment with COPAXONE® in Multiple Sclerosis Demonstrated Remyelination and Neuroprotective Effects in a Preclinical Setting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Oct 11 Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Oct 11 New Data on Teva’s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Oct 11 Teva Completes Acquisition of Cephalon Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Oct 11 Teva and Cephalon Receive European Commission Approval For Acquisition Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Oct 11 Significant Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with COPAXONE® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Oct 11 U.S. Federal Trade Commission Clears Teva's Acquisition of Cephalon Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 11 Teva to Report Third Quarter 2011 Financial Results on November 2, 2011 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Oct 11 Teva Respiratory Provides Resources for Patients Impacted by PRIMATENE® MIST Phase-Out Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Sep 11 Teva Solidifies Japanese Operations with Complete Buyout of Partner's Interest in Teva's Japanese Joint Venture Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Sep 11 Teva Announces Drug Development Investment in Cocrystal Discovery Inc. for Novel Antiviral Therapeutics Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
13 Sep 11 Teva Announces Additional Investment in CureTech Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 Aug 11 Teva Announces Court Adopts All Relevant Teva Claim Construction Interpretations in Copaxone® Patent Infringement Case against Sandoz/Momenta and Mylan/Natco; Court Denies Mylan’s Summary Judgment Motion of Invalidity Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Aug 11 Teva Receives FDA Acceptance of Its New Drug Application for BDP Nasal HFA for the Treatment of Allergic Rhinitis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Aug 11 Teva Receives European Marketing Authorization for ZOELY™ Oral Contraceptive Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Aug 11 Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 Jul 11 Teva Announces Launch of Camrese™ the Authorized Generic of Seasonique ® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Jul 11 Teva Completes Acquisition of Taiyo, the Third Largest Generics Company in Japan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jun 11 Teva Comments on Supreme Court Decision Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Jun 11 Teva and Cephalon Receive FTC Request for Additional Information Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Jun 11 Teva Signs $4 Billion Syndicated Credit Facilities Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Jun 11 Teva to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Jun 11 Teva Announces Successful Results of Phase III Study of Its Long-Acting G-CSF Product (Lipegfilgrastim) in Breast Cancer Patients Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising